1.
Exploring Cyclooxygenase-2 (COX-2) Inhibitors From Ascidian Derived Ligands For Cancer Treatment: An In-Silico Study. . CDF [Internet]. 2025 Feb. 10 [cited 2026 Feb. 20];54(2):3320-33. Available from: https://cuestionesdefisioterapia.com/index.php/es/article/view/1181